Zhi Su

Title: Zhi Su - Innovator in Cardiac Pharmacology

Introduction

Zhi Su is a notable inventor based in Vernon Hills, IL (US). He has made significant contributions to the field of cardiac pharmacology through his innovative patent. His work focuses on developing methods to assess the effects of various substances on living cells, particularly in cardiac preparations.

Latest Patents

Zhi Su holds a patent titled "High throughput, optical method and system for determining the effect of a test substance on non-contiguous living cells." This patent describes a rapid and efficient method and apparatus for detecting electrophysiologic, proarrhythmic, contractile, and other effects of substances such as compounds and drugs in native cellular cardiac preparations. The invention aims to provide a method to rapidly and efficiently detect and verify the effects of chemicals, compounds, and drugs on cardiac repolarization, contractility, and excitability using optically based techniques and customized simulation protocols. Additionally, it facilitates the rapid screening and selection of compounds for their electrophysiologic and proarrhythmic effects on cardiac myocytes.

Career Highlights

Zhi Su is currently associated with AbbVie Inc., a global biopharmaceutical company. His work at AbbVie focuses on advancing the understanding of cardiac responses to various pharmacological agents. His innovative approach has the potential to significantly impact drug development and safety assessments in cardiology.

Collaborations

Zhi Su has collaborated with esteemed colleagues such as Jonathan D. Trumbull and Gary A. Gintant. These collaborations have further enhanced the research and development efforts in the field of cardiac pharmacology.

Conclusion

Zhi Su's contributions to cardiac pharmacology through his innovative patent demonstrate his commitment to advancing medical science. His work not only enhances the understanding of cardiac responses but also paves the way for safer drug development.